# DiaMedica Therapeutics Inc.: Form 8-K, filed Sep 27, 2021

- Company: [DiaMedica Therapeutics Inc.](/companies/dmac.md) (CIK 1401040)
- Form: 8-K
- Filed: 2021-09-27
- Accepted by EDGAR: Sep 27, 2021, 08:45 ET
- Period: 2021-09-26
- Accession: 0001437749-21-022654
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1401040/000143774921022654/dmtp20210926_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1401040/000143774921022654/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1401040/000143774921022654/dmtp20210926_8k.htm

Filed Sep 27, 2021.
Source: SEC EDGAR, the filing index for accession 0001437749-21-022654. Last ingested by Listed: Nov 13, 2026, 16:25 ET. No prices; not investment advice.
